Neither replication nor simulation supports a role for the axon guidance pathway in the genetics of Parkinson's disease.

Susceptibility to sporadic Parkinson's disease (PD) is thought to be influenced by both genetic and environmental factors and their interaction with each other. Statistical models including multiple variants in axon guidance pathway genes have recently been purported to be capable of predicting...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yonghong Li, Charles Rowland, Georgia Xiromerisiou, Robert J Lagier, Steven J Schrodi, Efthimios Dradiotis, David Ross, Nam Bui, Joseph Catanese, Konstantinos Aggelakis, Andrew Grupe, Georgios Hadjigeorgiou
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2008
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c57d7bfd012248119155fb5e2e79c332
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c57d7bfd012248119155fb5e2e79c332
record_format dspace
spelling oai:doaj.org-article:c57d7bfd012248119155fb5e2e79c3322021-11-25T06:11:35ZNeither replication nor simulation supports a role for the axon guidance pathway in the genetics of Parkinson's disease.1932-620310.1371/journal.pone.0002707https://doaj.org/article/c57d7bfd012248119155fb5e2e79c3322008-07-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18628988/?tool=EBIhttps://doaj.org/toc/1932-6203Susceptibility to sporadic Parkinson's disease (PD) is thought to be influenced by both genetic and environmental factors and their interaction with each other. Statistical models including multiple variants in axon guidance pathway genes have recently been purported to be capable of predicting PD risk, survival free of the disease and age at disease onset; however the specific models have not undergone independent validation. Here we tested the best proposed risk panel of 23 single nucleotide polymorphisms (SNPs) in two PD sample sets, with a total of 525 cases and 518 controls. By single marker analysis, only one marker was significantly associated with PD risk in one of our sample sets (rs6692804: P = 0.03). Multi-marker analysis using the reported model found a mild association in one sample set (two sided P = 0.049, odds ratio for each score change = 1.07) but no significance in the other (two sided P = 0.98, odds ratio = 1), a stark contrast to the reported strong association with PD risk (P = 4.64x10(-38), odds ratio as high as 90.8). Following a procedure similar to that used to build the reported model, simulated multi-marker models containing SNPs from randomly chosen genes in a genome wide PD dataset produced P-values that were highly significant and indistinguishable from similar models where disease status was permuted (3.13x10(-23) to 4.90x10(-64)), demonstrating the potential for overfitting in the model building process. Together, these results challenge the robustness of the reported panel of genetic markers to predict PD risk in particular and a role of the axon guidance pathway in PD genetics in general.Yonghong LiCharles RowlandGeorgia XiromerisiouRobert J LagierSteven J SchrodiEfthimios DradiotisDavid RossNam BuiJoseph CataneseKonstantinos AggelakisAndrew GrupeGeorgios HadjigeorgiouPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 3, Iss 7, p e2707 (2008)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Yonghong Li
Charles Rowland
Georgia Xiromerisiou
Robert J Lagier
Steven J Schrodi
Efthimios Dradiotis
David Ross
Nam Bui
Joseph Catanese
Konstantinos Aggelakis
Andrew Grupe
Georgios Hadjigeorgiou
Neither replication nor simulation supports a role for the axon guidance pathway in the genetics of Parkinson's disease.
description Susceptibility to sporadic Parkinson's disease (PD) is thought to be influenced by both genetic and environmental factors and their interaction with each other. Statistical models including multiple variants in axon guidance pathway genes have recently been purported to be capable of predicting PD risk, survival free of the disease and age at disease onset; however the specific models have not undergone independent validation. Here we tested the best proposed risk panel of 23 single nucleotide polymorphisms (SNPs) in two PD sample sets, with a total of 525 cases and 518 controls. By single marker analysis, only one marker was significantly associated with PD risk in one of our sample sets (rs6692804: P = 0.03). Multi-marker analysis using the reported model found a mild association in one sample set (two sided P = 0.049, odds ratio for each score change = 1.07) but no significance in the other (two sided P = 0.98, odds ratio = 1), a stark contrast to the reported strong association with PD risk (P = 4.64x10(-38), odds ratio as high as 90.8). Following a procedure similar to that used to build the reported model, simulated multi-marker models containing SNPs from randomly chosen genes in a genome wide PD dataset produced P-values that were highly significant and indistinguishable from similar models where disease status was permuted (3.13x10(-23) to 4.90x10(-64)), demonstrating the potential for overfitting in the model building process. Together, these results challenge the robustness of the reported panel of genetic markers to predict PD risk in particular and a role of the axon guidance pathway in PD genetics in general.
format article
author Yonghong Li
Charles Rowland
Georgia Xiromerisiou
Robert J Lagier
Steven J Schrodi
Efthimios Dradiotis
David Ross
Nam Bui
Joseph Catanese
Konstantinos Aggelakis
Andrew Grupe
Georgios Hadjigeorgiou
author_facet Yonghong Li
Charles Rowland
Georgia Xiromerisiou
Robert J Lagier
Steven J Schrodi
Efthimios Dradiotis
David Ross
Nam Bui
Joseph Catanese
Konstantinos Aggelakis
Andrew Grupe
Georgios Hadjigeorgiou
author_sort Yonghong Li
title Neither replication nor simulation supports a role for the axon guidance pathway in the genetics of Parkinson's disease.
title_short Neither replication nor simulation supports a role for the axon guidance pathway in the genetics of Parkinson's disease.
title_full Neither replication nor simulation supports a role for the axon guidance pathway in the genetics of Parkinson's disease.
title_fullStr Neither replication nor simulation supports a role for the axon guidance pathway in the genetics of Parkinson's disease.
title_full_unstemmed Neither replication nor simulation supports a role for the axon guidance pathway in the genetics of Parkinson's disease.
title_sort neither replication nor simulation supports a role for the axon guidance pathway in the genetics of parkinson's disease.
publisher Public Library of Science (PLoS)
publishDate 2008
url https://doaj.org/article/c57d7bfd012248119155fb5e2e79c332
work_keys_str_mv AT yonghongli neitherreplicationnorsimulationsupportsarolefortheaxonguidancepathwayinthegeneticsofparkinsonsdisease
AT charlesrowland neitherreplicationnorsimulationsupportsarolefortheaxonguidancepathwayinthegeneticsofparkinsonsdisease
AT georgiaxiromerisiou neitherreplicationnorsimulationsupportsarolefortheaxonguidancepathwayinthegeneticsofparkinsonsdisease
AT robertjlagier neitherreplicationnorsimulationsupportsarolefortheaxonguidancepathwayinthegeneticsofparkinsonsdisease
AT stevenjschrodi neitherreplicationnorsimulationsupportsarolefortheaxonguidancepathwayinthegeneticsofparkinsonsdisease
AT efthimiosdradiotis neitherreplicationnorsimulationsupportsarolefortheaxonguidancepathwayinthegeneticsofparkinsonsdisease
AT davidross neitherreplicationnorsimulationsupportsarolefortheaxonguidancepathwayinthegeneticsofparkinsonsdisease
AT nambui neitherreplicationnorsimulationsupportsarolefortheaxonguidancepathwayinthegeneticsofparkinsonsdisease
AT josephcatanese neitherreplicationnorsimulationsupportsarolefortheaxonguidancepathwayinthegeneticsofparkinsonsdisease
AT konstantinosaggelakis neitherreplicationnorsimulationsupportsarolefortheaxonguidancepathwayinthegeneticsofparkinsonsdisease
AT andrewgrupe neitherreplicationnorsimulationsupportsarolefortheaxonguidancepathwayinthegeneticsofparkinsonsdisease
AT georgioshadjigeorgiou neitherreplicationnorsimulationsupportsarolefortheaxonguidancepathwayinthegeneticsofparkinsonsdisease
_version_ 1718414068799242240